Search results
Jun 5, 2020 · The SEC alleged that Stiefel Laboratories and Charles Stiefel used artificially low valuations for stock buybacks and failed to disclose information that would have alerted employee shareholders their stock was worth much more than the price the company paid them.
On December 12, 2011, the Commission filed a complaint (the “Complaint”) against Stiefel Laboratories Inc. (“Stiefel Labs”) and Charles W. Stiefel (“Stiefel”), it’s Chairman and Chief Executive Officer (collectively, the “Defendants”).
Sep 22, 2023 · A series of claims totaling $24.5 million in damages filed against Stifel Nicolaus & Company alleges the firm, through Chuck A. Roberts and other brokers, breached its fiduciary duty to its customers through negligence and unauthorized trading, resulting in significant, multi-million dollar damages through product losses and generation of ...
comes before the Court on Plaintiff Securities and Exchange Commission’s (the “Commission”) Unopposed Motion for Entry of Final Judgments Against Defendants Stiefel Laboratories, Inc., and Charles W. Stiefel (“Stiefel”) and for the Court to Establish Fair Fund (the “Motion”) [ECF No. 232].
Dec 13, 2011 · Or so says the SEC in a new lawsuit filed in Miami alleging Stiefel defrauded investors of more than $100 million. "Stiefel made numerous misrepresentations and omissions to Stiefel Labs'...
The SEC alleged that Stiefel Laboratories and Charles Stiefel used artificially low valuations for stock buybacks and failed to disclose information that would have alerted employee shareholders their stock was worth much more than the price the company paid them.
Jul 12, 2022 · In December 2011, the SEC filed a complaint against Stiefel Laboratories Inc. (“Stiefel Labs”) and Charles W. Stiefel (“Stiefel”) (collectively, the “Defendants”).
